-
1
-
-
33644848963
-
Gallbladder cancer worldwide: geographical distribution and risk factors
-
Randi G., Franceschi S., La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int. J. Cancer 2006, 118:1591-1602.
-
(2006)
Int. J. Cancer
, vol.118
, pp. 1591-1602
-
-
Randi, G.1
Franceschi, S.2
La Vecchia, C.3
-
2
-
-
79961207743
-
Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis
-
Srivastava K., Srivastava A., Sharma K.L., Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat. Res 2011, 728:67-79.
-
(2011)
Mutat. Res
, vol.728
, pp. 67-79
-
-
Srivastava, K.1
Srivastava, A.2
Sharma, K.L.3
Mittal, B.4
-
3
-
-
84867847267
-
Gallbladder cancer: past, present and an uncertain future
-
Boutros C., Gary M., Baldwin K., Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg. Oncol 2012, 21:e183-e191.
-
(2012)
Surg. Oncol
, vol.21
, pp. e183-e191
-
-
Boutros, C.1
Gary, M.2
Baldwin, K.3
Somasundar, P.4
-
4
-
-
4544297463
-
Gallbladder cancer: lessons from a rare tumour
-
Wistuba I.I., Gazdar A.F. Gallbladder cancer: lessons from a rare tumour. Nat. Rev. Cancer 2004, 4:695-706.
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 695-706
-
-
Wistuba, I.I.1
Gazdar, A.F.2
-
5
-
-
67349125420
-
Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1
-
Wang J.W., Peng S.Y., Li J.T., Wang Y., Zhang Z.P., Cheng Y., et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett 2009, 281:71-81.
-
(2009)
Cancer Lett
, vol.281
, pp. 71-81
-
-
Wang, J.W.1
Peng, S.Y.2
Li, J.T.3
Wang, Y.4
Zhang, Z.P.5
Cheng, Y.6
-
6
-
-
84869854258
-
Function and cancer genomics of FAT family genes (review)
-
Katoh M. Function and cancer genomics of FAT family genes (review). Int. J. Oncol 2012, 41:1913-1918.
-
(2012)
Int. J. Oncol
, vol.41
, pp. 1913-1918
-
-
Katoh, M.1
-
7
-
-
30344454668
-
WW or WoW: the WW domains in a union of bliss
-
Sudol M., Recinos C.C., Abraczinskas J., Humbert J., Farooq A. WW or WoW: the WW domains in a union of bliss. IUBMB Life 2005, 57:773-778.
-
(2005)
IUBMB Life
, vol.57
, pp. 773-778
-
-
Sudol, M.1
Recinos, C.C.2
Abraczinskas, J.3
Humbert, J.4
Farooq, A.5
-
8
-
-
84879094799
-
YAP/TEAD-mediated transcription controls cellular senescence
-
Xie Q., Chen J., Feng H., Peng S., Adams U., Bai Y., et al. YAP/TEAD-mediated transcription controls cellular senescence. Cancer Res 2013, 73:3615-3624.
-
(2013)
Cancer Res
, vol.73
, pp. 3615-3624
-
-
Xie, Q.1
Chen, J.2
Feng, H.3
Peng, S.4
Adams, U.5
Bai, Y.6
-
9
-
-
84864007561
-
Yes-associated protein 1 is activated and functions as an oncogene in meningiomas
-
Baia G.S., Caballero O.L., Orr B.A., Lal A., Ho J.S., Cowdrey C., et al. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Mol. Cancer Res 2012, 10:904-913.
-
(2012)
Mol. Cancer Res
, vol.10
, pp. 904-913
-
-
Baia, G.S.1
Caballero, O.L.2
Orr, B.A.3
Lal, A.4
Ho, J.S.5
Cowdrey, C.6
-
10
-
-
84880549551
-
RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer
-
Lee S.E., Lee J.U., Lee M.H., Ryu M.J., Kim S.J., Kim Y.K., et al. RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer. Oncogenesis 2013, 2:e55.
-
(2013)
Oncogenesis
, vol.2
, pp. e55
-
-
Lee, S.E.1
Lee, J.U.2
Lee, M.H.3
Ryu, M.J.4
Kim, S.J.5
Kim, Y.K.6
-
11
-
-
84902001196
-
Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer
-
Lim B., Park J.L., Kim H.J., Park Y.K., Kim J.H., Sohn H.A., et al. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. Carcinogenesis 2014, 35:1020-1027.
-
(2014)
Carcinogenesis
, vol.35
, pp. 1020-1027
-
-
Lim, B.1
Park, J.L.2
Kim, H.J.3
Park, Y.K.4
Kim, J.H.5
Sohn, H.A.6
-
12
-
-
84878273791
-
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma
-
Tschaharganeh D.F., Chen X., Latzko P., Malz M., Gaida M.M., Felix K., et al. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology 2013, 144:1530-1542.
-
(2013)
Gastroenterology
, vol.144
, pp. 1530-1542
-
-
Tschaharganeh, D.F.1
Chen, X.2
Latzko, P.3
Malz, M.4
Gaida, M.M.5
Felix, K.6
-
13
-
-
84939894432
-
Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment
-
Sun P.L., Kim J.E., Yoo S.B., Kim H., Jin Y., Jheon S., et al. Cytoplasmic YAP expression is associated with prolonged survival in patients with lung adenocarcinomas and epidermal growth factor receptor tyrosine kinase inhibitor treatment. Ann. Surg. Oncol 2014, 10.1245/s10434-014-3715-5.
-
(2014)
Ann. Surg. Oncol
-
-
Sun, P.L.1
Kim, J.E.2
Yoo, S.B.3
Kim, H.4
Jin, Y.5
Jheon, S.6
-
14
-
-
84898016352
-
Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC)
-
Zhao Y., Zhou W., Xue L., Zhang W., Zhan Q. Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC). PLoS ONE 2014, 9:e90836.
-
(2014)
PLoS ONE
, vol.9
, pp. e90836
-
-
Zhao, Y.1
Zhou, W.2
Xue, L.3
Zhang, W.4
Zhan, Q.5
-
15
-
-
84896858407
-
TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3
-
Martianov I., Cler E., Duluc I., Vicaire S., Philipps M., Freund J.N., et al. TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3. PLoS ONE 2014, 9:e87365.
-
(2014)
PLoS ONE
, vol.9
, pp. e87365
-
-
Martianov, I.1
Cler, E.2
Duluc, I.3
Vicaire, S.4
Philipps, M.5
Freund, J.N.6
-
16
-
-
77954770827
-
Targeting YAP and Hippo signaling pathway in liver cancer
-
Liu A.M., Xu M.Z., Chen J., Poon R.T., Luk J.M. Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin. Ther. Targets 2010, 14:855-868.
-
(2010)
Expert Opin. Ther. Targets
, vol.14
, pp. 855-868
-
-
Liu, A.M.1
Xu, M.Z.2
Chen, J.3
Poon, R.T.4
Luk, J.M.5
-
17
-
-
79952532529
-
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
-
Xu M.Z., Chan S.W., Liu A.M., Wong K.F., Fan S.T., Chen J., et al. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 2011, 30:1229-1240.
-
(2011)
Oncogene
, vol.30
, pp. 1229-1240
-
-
Xu, M.Z.1
Chan, S.W.2
Liu, A.M.3
Wong, K.F.4
Fan, S.T.5
Chen, J.6
-
18
-
-
39149130681
-
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
-
Pinheiro C., Longatto-Filho A., Scapulatempo C., Ferreira L., Martins S., Pellerin L., et al. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch 2008, 452:139-146.
-
(2008)
Virchows Arch
, vol.452
, pp. 139-146
-
-
Pinheiro, C.1
Longatto-Filho, A.2
Scapulatempo, C.3
Ferreira, L.4
Martins, S.5
Pellerin, L.6
-
19
-
-
84875129380
-
MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer
-
Yu S.J., Hu J.Y., Kuang X.Y., Luo J.M., Hou Y.F., Di G.H., et al. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin. Cancer Res 2013, 19:1389-1399.
-
(2013)
Clin. Cancer Res
, vol.19
, pp. 1389-1399
-
-
Yu, S.J.1
Hu, J.Y.2
Kuang, X.Y.3
Luo, J.M.4
Hou, Y.F.5
Di, G.H.6
-
20
-
-
84880922644
-
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
-
Linger R.M., Cohen R.A., Cummings C.T., Sather S., Migdall-Wilson J., Middleton D.H., et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene 2013, 32:3420-3431.
-
(2013)
Oncogene
, vol.32
, pp. 3420-3431
-
-
Linger, R.M.1
Cohen, R.A.2
Cummings, C.T.3
Sather, S.4
Migdall-Wilson, J.5
Middleton, D.H.6
-
21
-
-
84870261155
-
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
-
Chen D., Sun Y., Wei Y., Zhang P., Rezaeian A.H., Teruya-Feldstein J., et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nat. Med 2012, 18:1511-1517.
-
(2012)
Nat. Med
, vol.18
, pp. 1511-1517
-
-
Chen, D.1
Sun, Y.2
Wei, Y.3
Zhang, P.4
Rezaeian, A.H.5
Teruya-Feldstein, J.6
-
22
-
-
0036463405
-
A matter of life and death
-
Green D.R., Evan G.I. A matter of life and death. Cancer Cell 2002, 1:19-30.
-
(2002)
Cancer Cell
, vol.1
, pp. 19-30
-
-
Green, D.R.1
Evan, G.I.2
-
23
-
-
84877277024
-
Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth
-
Lee M.H., Huang Z., Kim D.J., Kim S.H., Kim M.O., Lee S.Y., et al. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth. Cancer Prev. Res 2013, 6:455-465.
-
(2013)
Cancer Prev. Res
, vol.6
, pp. 455-465
-
-
Lee, M.H.1
Huang, Z.2
Kim, D.J.3
Kim, S.H.4
Kim, M.O.5
Lee, S.Y.6
-
24
-
-
0029849620
-
Cancer cell cycles
-
Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
-
(1996)
Science
, vol.274
, pp. 1672-1677
-
-
Sherr, C.J.1
-
25
-
-
84887184309
-
TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase
-
Wang X., Saso H., Iwamoto T., Xia W., Gong Y., Pusztai L., et al. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. Cancer Res 2013, 73:6516-6525.
-
(2013)
Cancer Res
, vol.73
, pp. 6516-6525
-
-
Wang, X.1
Saso, H.2
Iwamoto, T.3
Xia, W.4
Gong, Y.5
Pusztai, L.6
-
26
-
-
84890571120
-
The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications
-
Paccez J.D., Vogelsang M., Parker M.I., Zerbini L.F. The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications. Int. J. Cancer 2014, 134:1024-1033.
-
(2014)
Int. J. Cancer
, vol.134
, pp. 1024-1033
-
-
Paccez, J.D.1
Vogelsang, M.2
Parker, M.I.3
Zerbini, L.F.4
-
27
-
-
84875213848
-
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma
-
Pinato D.J., Mauri F.A., Lloyd T., Vaira V., Casadio C., Boldorini R.L., et al. The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesothelioma. Br. J. Cancer 2013, 108:621-628.
-
(2013)
Br. J. Cancer
, vol.108
, pp. 621-628
-
-
Pinato, D.J.1
Mauri, F.A.2
Lloyd, T.3
Vaira, V.4
Casadio, C.5
Boldorini, R.L.6
-
28
-
-
84871899423
-
The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells
-
Park H.J., Baen J.Y., Lee Y.J., Choi Y.H., Kang J.L. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells. Mol. Biol. Cell 2012, 23:3254-3265.
-
(2012)
Mol. Biol. Cell
, vol.23
, pp. 3254-3265
-
-
Park, H.J.1
Baen, J.Y.2
Lee, Y.J.3
Choi, Y.H.4
Kang, J.L.5
-
29
-
-
54049121368
-
Yes-associated protein (YAP) functions as a tumor suppressor in breast
-
Yuan M., Tomlinson V., Lara R., Holliday D., Chelala C., Harada T., et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008, 15:1752-1759.
-
(2008)
Cell Death Differ
, vol.15
, pp. 1752-1759
-
-
Yuan, M.1
Tomlinson, V.2
Lara, R.3
Holliday, D.4
Chelala, C.5
Harada, T.6
|